Kimberly Clark opened higher at $112.33, compared with its previous close of $110.02. In the last trading session, the stock traded between $108.26 and $112.82. It showed a downward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Kimberly Clark is now worth
$ 84.26
resulting in a loss of
$ 15.74 (15.74%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 12 Analysts
Buy
41.67%
Hold
58.33%
Sell
0%
Markets Today
Today's Change
$-0.91 (-0.83%)
Day High
$112.82
Day Low
$108.26
Day Open
$112.33
Prev Close
$110.02
Volume
17,72,135
1W Return
-2.85%
1M Return
10.23%
3M Return
-3.61%
6M Return
13.53%
1Y Return
-6.52%
Fundamentals
Market Cap ($ Mn)
36,287
PE Ratio
21.61
PB Ratio
20.82
PEG Ratio
15.53
ROE
136.37%
ROCE
23.64%
EPS (TTM)
$1.04
Investment Returns
1 Week
-2.85%
1 Month
10.23%
3 Months
-3.61%
6 Months
13.53%
9 Months
10.59%
Financials
Quarterly
All values in $ Mn
4.8K
Mar 25
4.2K
Jun 25
4.2K
Sep 25
4.1K
Dec 25
4.2K
Mar 26
4.2K
Jun 26
Updates
20Oct
China approves Kimberly-Clark's Kenvue acquisition on Oct 10
China's SAMR granted unconditional approval for the acquisition. Approval date was October 10, 2026. Removes a key antitrust hurdle for the Kimberly-Clark and Kenvue deal. No remedies or divestitures required in China.
10 days ago
20Oct
Kimberly-Clark prices $4.9B senior notes to fund Kenvue acquisition
Priced a total of $4.9 billion in senior notes. Issued in five tranches with coupons between 5.100% and 5.800%. Proceeds designated for Kenvue acquisition cash consideration. Closing expected on October 29, 2026.
10 days ago
16Oct
BNP Paribas maintains neutral on Kimberly-Clark, raises target to $110
BNP Paribas maintains a Neutral rating on Kimberly-Clark. Price target raised from $101 to $110 by analyst Kevin Grundy. No change in investment stance despite higher valuation outlook.
13 days ago
15Oct
Kimberly-Clark Q3FY26 Results: Adjusted EPS rises 17% to $1.70
Adjusted EPS from continuing operations rose 17% YoY to $1.70. Net sales declined 0.4% YoY to $4.134 billion; organic sales fell 1.3%. Full-year 2026 outlook reaffirmed with mid-single-digit constant-currency operating profit growth. Cash and cash equivalents increased to $1.874 billion from $617 million. Diluted EPS surged to $5.37 driven by a one-time transaction gain.
15 days ago
13Oct
EU Commission approves Kimberly-Clark's Kenvue buy with conditions
European Commission grants conditional approval for the merger. Clearance depends on strict adherence to offered commitments. Decision addresses potential competition concerns in consumer goods.
17 days ago
16Sep
Kimberly-Clark May Sell Assets to Clear $40 Billion Kenvue Deal
Kimberly-Clark prepares concessions for EU antitrust review of $40 billion Kenvue deal. Australia mandated sale of Stayfree and Carefree brands to preserve competition. Stock down 21.09% over 12 months despite trading near oversold RSI levels. Analyst consensus remains Hold with average price target of $112.43.
